Catalyst Biosciences Stock Current Valuation

CBIODelisted Stock  USD 0.41  0.02  4.65%   
Valuation analysis of Catalyst Biosciences helps investors to measure Catalyst Biosciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
0.41
Please note that Catalyst Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Catalyst Biosciences is based on 3 months time horizon. Increasing Catalyst Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Catalyst Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Catalyst Stock. However, Catalyst Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.41 Real  0.31 Hype  0.41 Naive  0.42
The intrinsic value of Catalyst Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Catalyst Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.31
Real Value
0.45
Upside
Estimating the potential upside or downside of Catalyst Biosciences helps investors to forecast how Catalyst stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Catalyst Biosciences more accurately as focusing exclusively on Catalyst Biosciences' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.400.420.44
Details
Hype
Prediction
LowEstimatedHigh
0.410.410.41
Details
Potential
Annual Dividend
LowForecastedHigh
0.080.080.08
Details

Catalyst Biosciences Company Current Valuation Analysis

Catalyst Biosciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Catalyst Biosciences Current Valuation

    
  51.03 M  
Most of Catalyst Biosciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Catalyst Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Catalyst Biosciences has a Current Valuation of 51.03 M. This is 99.64% lower than that of the Biotechnology sector and 98.9% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.69% higher than that of the company.

Catalyst Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Catalyst Biosciences' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Catalyst Biosciences could also be used in its relative valuation, which is a method of valuing Catalyst Biosciences by comparing valuation metrics of similar companies.
Catalyst Biosciences is currently under evaluation in current valuation category among its peers.

Catalyst Fundamentals

About Catalyst Biosciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Catalyst Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Catalyst Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Catalyst Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Catalyst Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Catalyst Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Catalyst Stock

  0.91MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.88HYMTF Hyundai MotorPairCorr
  0.86TLK Telkom Indonesia TbkPairCorr
  0.86PFE Pfizer Inc Aggressive PushPairCorr
  0.79JNJ Johnson Johnson Sell-off TrendPairCorr
The ability to find closely correlated positions to Catalyst Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Catalyst Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Catalyst Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Catalyst Biosciences to buy it.
The correlation of Catalyst Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Catalyst Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Catalyst Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Catalyst Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in Catalyst Stock

If you are still planning to invest in Catalyst Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalyst Biosciences' history and understand the potential risks before investing.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Valuation
Check real value of public entities based on technical and fundamental data
Share Portfolio
Track or share privately all of your investments from the convenience of any device